woman writing on board

Environmental, Social & Governance (ESG)

We’re advancing ESG initiatives that contribute to our sustainable growth, so that we can create a positive impact for generations to come. 


Our leaders are stewards of our environmental, social and governance mission, and our people are committed to ensuring our research, innovations and collaborations put impact for people, communities and our world first.

OUR APPROACH

Our ESG framework is built around three foundational pillars

We see our framework as an opportunity to apply the same rigor, curiosity and focus on science-based solutions to how we sustainably maintain and grow our business.

We discover and deliver innovative medicines.

We unlock the full potential of our diverse and talented teams and partners to deliver today and into the future.

We innovate with integrity and intention to advance long-term patient health and business resiliency.

Our Material Drivers

We periodically conduct materiality assessments to inform which environmental, social & governance (ESG) issues are most relevant to our business and our stakeholders. Reviewed and approved by executive leadership, we identified our material ESG topics by gathering and analyzing insights and feedback from a variety of internal and external stakeholders, including senior cross-functional ​leadership, employees, investors, community partners, patients, regulators and more. 

Product Innovation

We are committed to discovering and delivering innovative medicines aimed at addressing serious health conditions and improving the lives of patients.

PRODUCT QUALITY & SAFETY

We are committed to delivering safe and effective products and medicines through robust quality systems.

PATIENT HEALTH & ENGAGEMENT

We are dedicated to making a positive impact on health outcomes for patients worldwide

Business Ethics

We act with integrity in everything we do.


Resources

We’re transparent about our process

We’re guided by openness and transparency in our relationships with health care providers (HCPs), and health care organizations (HCOs). The objective of the Voluntary Disclosure of Payments initiative is to increase transparency about our operations in Canada and in doing so, increase trust with stakeholders within our healthcare system. Bringing greater transparency to these valuable and well-regulated relationships will contribute to enhancing trust and value for patients, as well as our healthcare system.